Both hydrochlorothiazide and spironolactone can be used to treat high blood pressure, but because spironolactone causes the body to flush out excess water and sodium and store potassium, the FDA warns that patients who mistakenly take it instead of hydrochlorothiazide could experience hyperkalemia, or elevated potassium levels.
The latest recall is on bottles of hydrochlorothiazide 12.5 mg USP tablets (100 count).
Bottles of 100 tablets of hydrochlorothiazide were incorrectly labeled and instead contained 100 25 mg tablets of spironolactone, according to a patient complaint made through a pharmacy.
The FDA has announced that Accord Healthcare is voluntarily recalling a blood pressure medication due to a mix-up.
Accord's hydrochlorothiazide pills are round and orange with an "H" imprinted on one side and "1" on the flip side.
Spironolactone is veteran to deal with congestive coronary heart failure, cirrhosis of the liver, extreme coronary heart failure, and other prerequisites.
For some, the medication mixup could be "life-threatening", according to the FDA's recall notice.
Accord believes that no other lots of Hydrochlorothiazide Tablets are involved in this mix-up. Hydrochlorothiazide is used to treat hypertension, also known as high blood pressure.
To date, the drugmaker has not received reports of adverse events in connection with the labeling mix-up.
Wholesalers, distributors, and retailers that have the recalled product have been advised to discontinue distribution of the product and notify consumers. Consumers that have the product should return the product to the pharmacy.
Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using the drug.